BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.

MLA

Grisham, Rachel N., et al. “BRAF Mutation Is Associated with Early Stage Disease and Improved Outcome in Patients with Low-Grade Serous Ovarian Cancer.” Cancer (0008543X), vol. 119, no. 3, Feb. 2013, pp. 548–54. EBSCOhost, https://doi.org/10.1002/cncr.27782.

APA

Grisham, R. N., Iyer, G., Garg, K., DeLair, D., Hyman, D. M., Zhou, Q., Iasonos, A., Berger, M. F., Dao, F., Spriggs, D. R., Levine, D. A., Aghajanian, C., & Solit, D. B. (2013). BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer. Cancer (0008543X), 119(3), 548–554. https://doi.org/10.1002/cncr.27782

Chicago

Grisham, Rachel N., Gopa Iyer, Karuna Garg, Deborah DeLair, David M. Hyman, Qin Zhou, Alexia Iasonos, et al. 2013. “BRAF Mutation Is Associated with Early Stage Disease and Improved Outcome in Patients with Low-Grade Serous Ovarian Cancer.” Cancer (0008543X) 119 (3): 548–54. doi:10.1002/cncr.27782.